Akhilesh Bhambhani
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Ultragenyx Pharmaceutical (United States)(US)
Publications by Year
Research Areas
Protein purification and stability, Viral Infectious Diseases and Gene Expression in Insects, Chemical Synthesis and Characterization, Monoclonal and Polyclonal Antibodies Research, Radioactive element chemistry and processing
Most-Cited Works
- → Formulation Design and High-Throughput Excipient Selection Based on Structural Integrity and Conformational Stability of Dilute and Highly Concentrated IgG1 Monoclonal Antibody Solutions(2011)66 cited
- → The Use of Flow Cytometry for the Detection of Subvisible Particles in Therapeutic Protein Formulations(2010)50 cited
- → Tuning the DNA binding modes of an anthracene derivative with salt(2005)48 cited
- → Spectroscopic Identification of Binding Modes of Anthracene Probes and DNA Sequence Recognition†(2005)45 cited
- → Novel formulations and drug delivery systems to administer biological solids(2021)43 cited
- → The Effects of Substituted Cyclodextrins on the Colloidal and Conformational Stability of Selected Proteins(2010)39 cited